Viewing Study NCT00920556


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-01 @ 9:47 AM
Study NCT ID: NCT00920556
Status: TERMINATED
Last Update Posted: 2019-02-27
First Post: 2009-06-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
Sponsor: Sirtris, a GSK Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-03-30
Start Date Type: ACTUAL
Primary Completion Date: 2010-11-04
Primary Completion Date Type: ACTUAL
Completion Date: 2010-11-04
Completion Date Type: ACTUAL
First Submit Date: 2009-06-12
First Submit QC Date: None
Study First Post Date: 2009-06-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-09-28
Results First Submit QC Date: None
Results First Post Date: 2019-02-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-10-17
Last Update Post Date: 2019-02-27
Last Update Post Date Type: ACTUAL